Bain Capital Public Equity Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,262,328
Closed -$9.23M – 12
2019
Q1
$9.23M Buy
1,262,328
+355,662
+39% +$3.48M 0.88% 29
2018
Q4
$8.3M Buy
+906,666
New +$10M 0.78% 32
2018
Q3
– Sell
-275,262
Closed -$4.2M – 71
2018
Q2
$4.2M Buy
+275,262
New +$4.76M 0.28% 46
2018
Q1
– Sell
-249,052
Closed -$4.66M – 76
2017
Q4
$4.66M Buy
+249,052
New +$5M 0.34% 51
2017
Q3
– Sell
-491,300
Closed -$4.74M – 69
2017
Q2
$4.74M Buy
+491,300
New +$3.19M 0.29% 43
2014
Q3
– Sell
-527,494
Closed -$8.44M – 55
2014
Q2
$8.44M Sell
527,494
-187,510
-26% -$2.83M 0.2% 55
2014
Q1
$12.9M Sell
715,004
-84,996
-11% -$1.58M 0.34% 44
2013
Q4
$15.7M Buy
+800,000
New +$11.7M 0.44% 38

Other funds holding DVAX

Bain Capital Public Equity Management's DVAX Position: Q2 2019 in Review

Bain Capital Public Equity Management sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 1,262,328 shares — an estimated $9.23M sold.

Bain Capital Public Equity Management first reported a position in DVAX in Q4 2013 and held it in 8 quarters. The position peaked at $15.7M in Q4 2013. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

  • Bain Capital Public Equity Management reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 1,262,328 Dynavax Technologies shares in Q2 2019, an estimated $9.23M.
  • Bain Capital Public Equity Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 8 quarters.
  • Bain Capital Public Equity Management's Dynavax Technologies position peaked at $15.7M in Q4 2013.
  • 127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2019.